AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis (Q34539350)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis |
scientific article |
Statements
1 reference
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis (English)
1 reference
Alexandros Makriyannis
1 reference
Kathline Kim
1 reference
Dan H Moore
1 reference
1 reference
Identifiers
1 reference